NCT03948087

Brief Summary

Comparison of wound healing, edema level, knee range of motion, rate of revision post falls, device application time, time to prosthetic fit, and cost between postoperative soft dressing and a vacuum removable rigid dressing after unilateral transtibial amputation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 13, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

May 13, 2019

Status Verified

May 1, 2019

Enrollment Period

1.4 years

First QC Date

February 27, 2019

Last Update Submit

May 10, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of Change in Stump Wound Healing

    The Photographic Wound Assessment Tool (PWAT) will be used in a blinded fashion to evaluate the level of change in wound healing of the transtibial amputation primary closure. The PWAT incorporates type and amount of necrotic tissue, wound edge definition, surrounding skin color, epithelialization, and granulation of tissue. A score of 0/24 on the PWAT indicates complete wound closure.

    Day 3,7,14,30,48

Secondary Outcomes (6)

  • Evaluation of Change in Level of Limb Edema

    Day 3,7,14,30,48

  • Evaluation of Change in Knee Range of Motion

    Day 3,7,14,30,48

  • Rate of Revision Post Falls

    Until prosthetic limb fit, on average 2 months.

  • Total Amount of Time to Apply, Change, Clean and Alter the Dressings

    Until discharge from acute care, on average 2 weeks.

  • Length of time Until the Residual Limb is Ready for Prosthetic Fitting

    Through study completion, on average 2 months.

  • +1 more secondary outcomes

Study Arms (2)

Vacuum Removable Rigid Dressing (VRRD)

EXPERIMENTAL

Application of a Vacuum Removable Rigid Dressing (VRRD)

Device: Vacuum Removable Rigid Dressing (VRRD)

Soft Dressing Control Group

NO INTERVENTION

Application of standard of care soft dressing (SD) intra-operatively.

Interventions

Intra-operative application of device.

Also known as: Ossur (TM) Rigid Dressing (ORD)
Vacuum Removable Rigid Dressing (VRRD)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Transtibial amputation related to peripheral vascular disease with or without diabetes or trauma.
  • Justification: The form and function of the ORD device relates solely to transtibial amputees. The device is not useable for any other limb amputation type (e.g. transfemoral, transmetatarsal). The choice of using vascular compromised participants is intentional. Ischemia and necrosis rapidly ensue as a result of vessel occlusion which can easily happen with any external compressive force (e.g. tensor bandaging). The ORD does not apply compressive force to the residual limb.
  • Transtibial amputation that includes myodesis and/or myoplasty.
  • Justification: Myoplasty and myodesis are preferred surgical techniques while performing an amputation. They involve the surgical attachment of muscle to muscle (myoplasty) or muscle to bone (myodesis) across the end of the residual limb prior to skin flap closure. This allows increased stability and provides a better interface with a future prosthetic device.
  • Greater than 18 years of age
  • Justification: Below the age of 18 informed consent must be obtained by a parent or guardian
  • Patient must be able to speak and understand English in order to provide informed consent. No reliance on translator services will be implemented.
  • Has no major illness where life expectancy is less than 2 years.
  • Justification: This is the study timeline and co-morbidities that limit participation within this timeframe will introduce confounding factors.

You may not qualify if:

  • Severe dementia or insufficient cognition.
  • Justification: Inability to provide informed consent to participate in the study.
  • Knee contracture greater than 30 degrees
  • Justification: The ORD will not fit a limb with too much flexion at the knee. Wound healing is also affected due to pressure across the end of the residual limb without the use of offloading techniques.
  • Severe peripheral vascular disease involving the contralateral lower limb
  • Justification: Having severe peripheral vascular disease to the contralateral limb may affect the secondary outcome measures due to the need for further medical or surgical intervention.
  • Inability to speak, read, or understand English.
  • Justification: For a patient to participate in the study informed consent must be obtained. There is a high probability that there would be too much variability among translators (family member or institutional) to ensure consistent informed consent.
  • Neurological condition or medical disorder that could affect rehabilitation.
  • Justification: Rehabilitation post transtibial amputation is critical to overall functional outcomes as well as study outcomes. If a patient has difficulty with participation in rehabilitation then this will be a confounding factor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Trent I Duchscherer, MSc

    Amputee Coordinator Northern Alberta Vascular Center

    PRINCIPAL INVESTIGATOR
  • Gerrit B Winkelaar, MD

    Divisional Director and Clinical Head of Vascular Surgery for the Edmonton zone

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Wound assessments will be determined in a blinded capacity by utilizing the Photographic Wound Assessment Tool. Photos of individual study participant's wounds will be taken and then assigned a non-identifying marker prior to being submitted by the wound assessor.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to an interventional group (vacuum rigid removable dressing) vs a non-interventional group (standard of care control group of soft dressing application).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Amputee Coordinator Northern Alberta Vascular Center

Study Record Dates

First Submitted

February 27, 2019

First Posted

May 13, 2019

Study Start

May 1, 2019

Primary Completion

October 1, 2020

Study Completion

May 1, 2021

Last Updated

May 13, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share